Abstract
Purpose
To examine the involvement of human SMCT1, a Na+-coupled transporter for short-chain fatty acids, in the transport of nicotinate/structural analogs and monocarboxylate drugs, and to analyze its expression in mouse intestinal tract.
Materials and Methods
We expressed human SMCT1 in X. laevis oocytes and monitored its function by [14C]nicotinate uptake and substrate-induced inward currents. SMCT1 expression in mouse intestinal tract was examined by immunofluorescence.
Results
[14C]Nicotinate uptake was several-fold higher in SMCT1-expressing oocytes than in water-injected oocytes. The uptake was inhibited by short-chain/medium-chain fatty acids and various structural analogs of nicotinate. Exposure of SMCT1-expressing oocytes to nicotinate induced Na+-dependent inward currents. Measurements of nicotinate flux and associated charge transfer into oocytes suggest a Na+:nicotinate stoichiometry of 2:1. Monocarboxylate drugs benzoate, salicylate, and 5-aminosalicylate are also transported by human SMCT1. The transporter is expressed in the small intestine as well as colon, and the expression is restricted to the lumen-facing apical membrane of intestinal and colonic epithelial cells.
Conclusions
Human SMCT1 transports not only nicotinate and its structural analogs but also various monocarboxylate drugs. The transporter is expressed on the luminal membrane of the epithelial cells lining the intestinal tract. SMCT1 may participate in the intestinal absorption of monocarboxylate drugs.
Similar content being viewed by others
References
S. Miyauchi, E. Gopal, Y. J. Fei, and V. Ganapathy. Functional identification of SLC5A8, a tumor suppressor down-regulated in colon cancer, as a Na+-coupled transporter for short-chain fatty acids. J. Biol. Chem. 279:13293–13296 (2004).
M. J. Coady, M. H. Chang, F. M. Charron, C. Plata, B. Wallendorff, J. F. Sah, S. D. Markowitz, M. F. Romero, and J. Y. Lapointe. The human tumour suppressor gene SLC5A8 expresses a Na+-monocarboxylate cotransporter. J. Physiol. 557:719–731 (2004).
E. Gopal, Y. J. Fei, M. Sugawara, S. Miyauchi, L. Zhuang, P. M. Martin, S. B. Smith, P. D. Prasad, and V. Ganapathy. Expression of slc5a8 in kidney and its role in Na+-coupled transport of lactate. J. Biol. Chem. 279:44522–44532 (2004).
H. Li, L. Myeroff, D. Smiraglia, M. F. Romero, T. P. Pretlow, L. Kasturi, J. Lutterbaugh, R. M. Rerko, G. Casey, J. P. Issa, J. Willis, J. K. Willson, C. Plass, and S. D. Markowitz. SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers. Proc. Natl. Acad. Sci. U. S. A. 100:8412–8417 (2003).
V. Ganapathy, E. Gopal, S. Miyauchi, and P. D. Prasad. Biological functions of SLC5A8, a candidate tumour suppressor. Biochem. Soc. Trans. 33:237–240 (2005).
N. Gupta, P. M. Martin, P. D. Prasad, and V. Ganapathy. SLC5A8 (SMCT1)-mediated transport of butyrate forms the basis for the tumor suppressive function of the transporter. Life Sci. 78:2419–2425 (2006).
M. Thangaraju, S. Ananth, P. M. Martin, P. Roon, S. B. Smith, E. Sterneck, P. D. Prasad, and V. Ganapathy. c/ebpd null mouse as a model for the double-knockout of slc5a8 and slc5a12 in kidney. J. Biol. Chem. 281:26769–26773 (2006).
P. M. Martin, E. Gopal, S. Ananth, L. Zuang, S. Itagaki, B. M. Prasad, S. B. Smith, P. D. Prasad, and V. Ganapathy. Identity of SMCT1 (SLC5A8) as a neuron-specific Na+-coupled transporter for active uptake of l-lactate and ketone bodies in the brain. J. Neurochem. 98:279–288 (2006).
R. L. Veech, B. Chance, Y. Kashiwaya, H. A. Lardy, and G. F. Cahill, Jr. Ketone bodies, potential therapeutic uses. IUBMB Life 51:241–247 (2001).
K. Casteels and C. Mathieu. Diabetic ketoacidosis. Rev. Endocr. Metab. Disord. 4:159–166 (2003).
A. M. Rodriguez, B. Perron, L. Lacroix, B. Caillou, G. Leblanc, M. Schlumberger, J. M. Bidart, and T. Pourcher. Identification and characterization of a putative human iodide transporter located at the apical membrane of thyrocytes. J. Clin. Endocrinol. Metab. 87:3500–3503 (2002).
V. Paroder, S. R. Spencer, M. Paroder, D. Arango, S. Schwartz, Jr., J. M. Mariadason, L. H. Augenlicht, S. Eskandari, and N. Carrasco. Na+/monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: molecular characterization of SMCT. Proc. Natl. Acad. Sci. U. S. A. 103:7270–7275 (2006).
E. Gopal, Y. J. Fei, S. Miyauchi, L. Zhuang, P. D. Prasad, and V. Ganapathy. Sodium-coupled and electrogenic transport of B-complex vitamin nicotinic acid by slc5a8, a member of the Na/glucose co-transporter gene family. Biochem. J. 388:309–316 (2005).
S. Itagaki, E. Gopal, L. Zuang, Y. J. Fei, S. Miyauchi, P. D. Prasad, and V. Ganapathy. Interaction of ibuprofen and other structurally related NSAIDs with the sodium-coupled monocarboxylate transporter SMCT1 (SLC5A8). Pharm. Res. 23:1209–1216 (2006).
H. Wang, Y. J. Fei, R. Kekuda, T. L. Yang-Feng, L. D. Devoe, F. H. Leibach, P. D. Prasad, and V. Ganapathy. Structure, function, and genomic organization of human Na+-dependent high-affinity dicarboxylate transporter. Am. J. Physiol. 278:C1019–C1030 (2000).
K. Inoue, Y. J. Fei, L. Zhuang, E. Gopal, S. Miyauchi, and V. Ganapathy. Functional features and genomic organization of mouse NaCT, a sodium-coupled transporter for tricarboxylic acid cycle intermediates. Biochem. J. 378:949–957 (2004).
S. Schuette and R. C. Rose. Renal transport and metabolism of nicotinic acid. Am. J. Physiol. 250:C694–C703 (1986).
K. Inoue, L. Zhuang, D. M. Maddox, S. B. Smith, and V. Ganapathy. Structure, function, and expression pattern of a novel sodium-coupled citrate transporter (NaCT) cloned from mammalian brain. J. Biol. Chem. 277:39469–39476 (2002).
K. Inoue, L. Zhuang, and V. Ganapathy. Human Na+-coupled citrate transporter (NaCT): Primary structure, genomic organization, and transport function. Biochem. Biophys. Res. Commun. 299:465–471 (2002).
K. Inoue, L. Zhuang, D. M. Maddox, S. B. Smith, and V. Ganapathy. Human NaCT, the ortholog of Drosophila Indy, as a novel target for lithium action. Biochem. J. 374:21–26 (2003).
M. Panayatova-Heiermann, D. D. Loo, and E. M. Wright. Kinetics of steady-state currents and charge movements associated with the rat Na+/glucose cotransporter. J. Biol. Chem. 270:27099–27105 (1995).
S. Eskandari, D. D. Loo, G. Dai, O. Levy, E. M. Wright, and N. Carrasco. Thyroid Na+/I− symporter. Mechanism, stoichiometry, and specificity. J. Biol. Chem. 272:27230–27238 (1997).
M. D. Regueiro. Diagnosis and treatment of ulcerative colitis. J. Clin. Gastroenterol. 38:733–740 (2004).
C. T. Xu, S. Y. Meng, and B. R. Pan. Drug therapy for ulcerative colitis. World J. Gastroenterol. 10:2311–2317 (2004).
R. P. MacDermott. Progress in understanding the mechanisms of action of 5-aminosalicylic acid. Am.J. Gastroenterol. 95:3343–3345 (2000).
J. P. Gisbert, F. Gomollon, J. Mate, and J. M. Pajares. Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review. Dig. Dis. Sci. 47:471–488 (2002).
B. E. Enerson, and L. R. Drewes. Molecular features, regulation, and function of monocarboxylate transporters: Implications for drug delivery. J. Pharm. Sci. 92:1531–1544 (2003).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gopal, E., Miyauchi, S., Martin, P.M. et al. Transport of Nicotinate and Structurally Related Compounds by Human SMCT1 (SLC5A8) and Its Relevance to Drug Transport in the Mammalian Intestinal Tract. Pharm Res 24, 575–584 (2007). https://doi.org/10.1007/s11095-006-9176-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-006-9176-1